Histamine-2 Receptor Antagonists and Proton Pump Inhibitors Are Associated With Reduced Risk of SARS-CoV-2 Infection Without Comorbidities Including Diabetes, Hypertension, and Dyslipidemia: A Propensity Score-Matched Nationwide Cohort Study.
Bokyung KimJin- Hyung JungKyung-Do HanSeungkyung KangEunwoo LeeHyunsoo ChungSang Gyun KimSoo-Jeong ChoPublished in: Journal of Korean medical science (2023)
H2RA and PPI use is associated with a decreased risk for SARS-CoV-2 infection but does not affect clinical outcome. Comorbidities including diabetes, hypertension, and dyslipidemia seem to offset the protective effect of H2RA and PPI.